What Elea does

Elea (Elea.ai GmbH) is a privately-held German healthcare AI company that builds AI-native clinical information systems, with two core products: elea Lab, a Pathology Operating System (LIS) that orchestrates the end-to-end pathology workflow from digital order entry and accessioning through grossing, staining, reporting, and billing, and elea ED, a mobile Information System for hospital emergency departments providing AI-powered speech-to-structure documentation and team coordination. The platform is architected around conversational AI, voice recognition, deep hardware integration (cassette/slide printers, staining machines, scanners via HL7 and FHIR), and an embedded agentic AI that generates structured, codeable reports in real time, with the proprietary pathology AI trained on 500,000+ cases.

The company is headquartered in Hamburg, Germany with operational offices in Freiburg and San Francisco, and is KV-certified in Germany and GDPR-compliant by design. Its go-to-market is sales-led, direct enterprise SaaS with quote-based pricing, anchored on a small set of named reference customers in Germany (Osnabrück, Gesundheit Nord, PATHORA, Dessau, Bremen) and a rapidly expanding U.S. footprint via a strategic Lumea partnership and anchor accounts including OnePath Diagnostics (largest North American customer) and GastroMed Miami. Revenue is generated primarily through recurring subscriptions for elea Lab and elea ED, supplemented by implementation, onboarding, and training professional services bundled with customer rollouts.

Elea is led by four co-founders (CEO Dr. Christoph Schröder, CMO Dr. Sebastian Casu, COO Stephan Frank, CTO Tobias Lygren) supported by a Head of Growth (Carlo Sirna, joined January 2026) and Chief of Staff. The company raised approximately $8.98M in a March 2025 round led by Fly Ventures and Giant Ventures, and is actively hiring across product, engineering, and commercial functions. No revenue, customer count, or headcount figures are publicly disclosed, and the company does not yet report ARR, GMV, or profitability metrics.

Name

Elea

Legal name

Elea.ai GmbH

Website

https://elea.health

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

11–50 employees

Short description

Elea builds AI-native healthcare information systems (elea Lab pathology LIS and elea ED emergency department platform) using voice-driven AI, agentic workflows, and deep hardware integration to automate clinical workflows for pathology labs, hospital systems, and multi-site networks in Germany and the United States.

Ownership category

akta.pro rank

Product category

Pathology Software

NAICS

Software Publishers (513210), Software Publishers (5132), Custom Computer Programming Services (541511)

SIC

Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Electronic Data Capture (EDC) Platforms (HLACAOAA)

akta.pro secondary industries

Enterprise Integration Engines & Interface Management (HL7 v2/X12/API) (HLACABAC), Data Engineering, Integration & ETL/ELT Services (BPAEAHAB)

Keywords

• Pathology operating system
• Clinical speech recognition
• Lab workflow automation
• Emergency department software
• Healthcare interoperability

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare SaaS Subscription (elea Lab): Recurring software subscription revenue from elea Lab (AI-native Pathology Operating System), sold to pathology labs, hospital systems, and multi-site pathology networks. Pricing is not publicly disclosed — quote-based enterprise deals. Scales across small labs to large nationwide networks.
2. Healthcare SaaS Subscription (elea ED): Recurring subscription revenue from elea ED, the AI-powered Emergency Department Information System. Targets hospital EDs and emergency care teams; pricing not publicly disclosed.
3. Implementation, Onboarding & Training Services: Professional services for onboarding, role-based training, interoperability integration with existing IT systems, and ongoing partnership-based support. Included as part of customer rollout.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Core offering

Elea sells AI-powered healthcare information systems, primarily elea Lab (an AI-native Pathology Operating System that orchestrates the end-to-end pathology workflow from accession through final report) and elea ED (an AI-powered Emergency Department Information System for real-time clinical documentation). The platform replaces fragmented legacy LIS, dictation, and reporting stacks with a single conversational AI system that captures voice input, generates structured reports, controls lab hardware, and integrates with hospital systems via HL7 and FHIR standards.

Product overview

Elea offers a platform-plus-modules architecture of AI-powered healthcare information systems centered on two core products: elea Lab, the AI-native Pathology Operating System that orchestrates the entire pathology workflow from accession through final report, and elea ED, the AI-powered Emergency Department Information System for real-time clinical documentation and team coordination. Both products share elea's AI-native foundation — built on conversational AI, voice recognition, deep hardware integration, and an embedded agentic AI that runs continuously across clinical workflows — and connect to external partners via HL7/FHIR-based interoperability with image management systems, scanners, and laboratory devices.

Differentiator

Problem solved

Functional benefit

Brands

• elea Lab: AI-powered Pathology Operating System (LIS) that orchestrates the end-to-end pathology laboratory workflow, including accessioning, lab processing, slide tracking, reporting, and case sign-out.
• elea ED

Products and services

• elea Lab AI-native Pathology Operating System that unifies lab hardware and data, automates documentation, and connects partner labs and hospitals in one platform. Supports the full end-to-end pathology workflow from digital order entry through macroscopic examination, complete laboratory process, histological assessment, report creation, and report delivery, with a Pathology AI trained on 500,000+ cases.
• elea ED Mobile AI-powered Information System for Emergency Departments that simplifies every workflow end-to-end and improves documentation accuracy. Provides AI-powered speech-to-structure documentation, clinical workflow coordination, standard operating procedures, handover summaries, inter-role communication, and resource/capacity management via live dashboards.

Quantifiable outcome

• 85+% review & approval completed in under 30 seconds
• +6 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature12 records

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

• GastroMed (Miami)coreStrategic or Co-development Partner · 27 May 2026GastroMed becomes elea's first laboratory partner in Florida, marking a targeted step in elea's U.S. expansion. GastroMed implements elea Lab to consolidate accession, lab processes, dictation, and reporting into a single end-to-end environment for gastrointestinal pathology. The deployment spans 7 practice locations and 4 endoscopy centers with 15 board-certified gastroenterologists.
• OnePath DiagnosticsflagshipStrategic or Co-development Partner · 8 May 2026Strategic partnership deploying elea's Pathology Operating System as the central platform orchestrating workflow across OnePath's nationwide sub-specialty network. OnePath is one of the largest pathology groups in the U.S., headquartered in Jacksonville, FL, and the deployment makes OnePath elea's largest customer in North America. Integration underway across central operations at the time of announcement.
• Ignis Labs (Ignis Design Agency)minorImplementation/ SI/ Consulting Partner · 1 April 2026Elea worked with Ignis Design Agency to design and develop the relaunched elea.health website (launched April 2026).
• LumeaflagshipStrategic or Co-development Partner · 17 March 2026Strategic partnership combining Lumea's FDA-cleared IMS Viewer+ with elea's AI-native agentic LIS to create a unified pathology ecosystem. Targets the U.S. market with a 'one-screen, one-workspace' experience enabling voice-driven AI navigation and zero manual data re-entry. Lumea is elea's preferred digital pathology partner for its U.S. launch; both companies co-showcased the unified ecosystem at USCAP 2026 in San Antonio (March 21–26, 2026).
• PATHORA (Sven Perner)minorOthers · 17 March 2026Elea sponsored and exhibited at the 2nd PATHORA Symposium on Bladder Cancer in Reutlingen following the invitation of Prof. Dr. med. Sven Perner. PATHORA customers (Professors and Specialists in Pathology) also provide testimonials for elea Lab.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• PathAI: AI pathology company developing diagnostic and drug-development tools for pathology. Overlaps with Elea in bringing AI into routine pathology lab workflows and is a direct competitor for AI-driven pathology budgets at large hospital systems and pharma.
• Ibex Medical Analytics: AI-powered cancer diagnostics platform for pathology, deployed in clinical workflows at hospital and reference labs. Closely comparable in applying AI to routine pathology case review and quality assurance, and a credible alternative for labs evaluating AI-native workflow tools.
• Indica Labs: Provider of AI-powered digital pathology image-analysis software deployed in clinical and research labs. Comparable to Elea as a software-led pathology AI vendor selling into hospital and reference-lab customers, although Indica is more focused on image analysis and pharma research workflows.
• Paige.AI: AI-native digital pathology company offering AI-powered cancer detection and diagnostics tools for pathology labs. Directly comparable to Elea in applying AI to pathology workflows, although Paige focuses more on image-based AI whereas Elea's edge is workflow/LIS orchestration and voice-driven structured reporting.
• Proscia: Digital pathology platform provider offering an AI-enabled enterprise pathology platform for diagnostic workflows and image management. Directly comparable to Elea's pathology-focused software play, with a similar enterprise SaaS GTM motion to hospital and reference labs.

Broad incumbents

• DeepHealth (by RadNet): AI-powered diagnostic imaging and population-health platform, now part of RadNet, that applies AI to clinical imaging workflows. Comparable in bringing AI into clinical diagnostic workflows and in targeting hospital/health-system buyers, though primarily in radiology rather than pathology.
• Dedalus Group: Major European healthcare IT vendor offering laboratory and diagnostic information systems across multiple countries including Germany. Comparable to Elea on the LIS side and to Elea's home German market, but as a broad incumbent with multi-decade hospital relationships rather than an AI-native challenger.
• Sectra: Large established provider of digital pathology and LIS solutions to hospitals across Europe and the US. Comparable as a competing LIS/digital pathology incumbent that Elea must displace in enterprise procurements, but offers AI capabilities as part of a much broader imaging-IT portfolio.

Others

• Lumea: FDA-cleared digital pathology IMS viewer provider that is Elea's preferred U.S. distribution partner. Lumea's image-management system complements Elea's LIS, and the two companies have a flagship co-marketed 'one-screen, one-workspace' ecosystem, making Lumea the most direct channel partner rather than a direct competitor.

Emerging players

• Smart Reporting: Germany-based AI-powered structured reporting vendor for radiology and pathology. Closely comparable to Elea's automated, AI-generated structured-reporting value proposition and to Elea's home German market, with overlapping customer personas in hospital diagnostic departments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/elea-ai

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elea